Track protection status across key markets to assess launch feasibility.
It is formulated by 25 pharmaceutical companies such as ALLERGAN, ALMIRALL, UPSHER SMITH LABS and others. It is marketed under 13 brand names, including TRETINOIN, VELTIN, MYORISAN and others. Available in 22 different strengths, such as 0.0375%, 1.2%;0.025%, 10MG and others, and administered through 4 routes including CREAM;TOPICAL, GEL;TOPICAL, CAPSULE;ORAL and others.
API availability: Loading API feasibility...
Licensing: 25 potential partnersUS Launch window: Loading launch window...
Stay ahead with worldwide patent expiry and latest updates.
FDA approval history for this ingredient
Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.
Key expiration dates for US patents covering this ingredient
Stay ahead with worldwide patent expiry insights, market data, and research updates.
Latest drug strengths approved by FDA
Strength | Route of Administration | Companies | Latest Approval Date |
---|
Patents approved by the FDA for the ingredient
|
Patent Number | Publication Date | Legal Status | Patent Expiry Date | |
---|---|---|---|---|---|
{"application_id":"55313","ingredient":"BENZOYL PEROXIDE; TRETINOIN","trade_name":"TWYNEO","family_id":"5d007a5c412a4bc680d0","publication_number":"US8617580B2","cleaned_patent_number":"8617580","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2028-02-03","publication_date":"2013-12-31","legal_status":"Granted"} | US8617580B2 Formulation | 31 Dec, 2013 | Granted | 03 Feb, 2028 | |
{"application_id":"139373","ingredient":"BENZOYL PEROXIDE; TRETINOIN","trade_name":"TWYNEO","family_id":"","publication_number":"US12156946B2","cleaned_patent_number":"12156946","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2028-02-03","publication_date":"2024-12-03","legal_status":"Granted"} | US12156946B2 Formulation | 03 Dec, 2024 | Granted | 03 Feb, 2028 | |
{"application_id":"54689","ingredient":"BENZOYL PEROXIDE; TRETINOIN","trade_name":"TWYNEO","family_id":"09f0af1bbf23403187bc","publication_number":"US9868103B2","cleaned_patent_number":"9868103","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2028-08-08","publication_date":"2018-01-16","legal_status":"Granted"} | US9868103B2 Formulation | 16 Jan, 2018 | Granted | 08 Aug, 2028 | |
{"application_id":"55308","ingredient":"BENZOYL PEROXIDE; TRETINOIN","trade_name":"TWYNEO","family_id":"de51050de26e48cf8be1","publication_number":"US20210290985A1","cleaned_patent_number":"12070629","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-12-30","publication_date":"2021-09-23","legal_status":"Pending"} | US12070629B2 Formulation | 23 Sep, 2021 | Pending | 30 Dec, 2030 | |
{"application_id":"55306","ingredient":"BENZOYL PEROXIDE; TRETINOIN","trade_name":"TWYNEO","family_id":"de51050de26e48cf8be1","publication_number":"US11071878B2","cleaned_patent_number":"11071878","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-12-30","publication_date":"2021-07-27","legal_status":"Granted"} | US11071878B2 Formulation | 27 Jul, 2021 | Granted | 30 Dec, 2030 | |
{"application_id":"55293","ingredient":"BENZOYL PEROXIDE; TRETINOIN","trade_name":"TWYNEO","family_id":"de51050de26e48cf8be1","publication_number":"US10653899B2","cleaned_patent_number":"10653899","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-12-30","publication_date":"2020-05-19","legal_status":"Granted"} | US10653899B2 Formulation | 19 May, 2020 | Granted | 30 Dec, 2030 | |
{"application_id":"130692","ingredient":"BENZOYL PEROXIDE; TRETINOIN","trade_name":"TWYNEO","family_id":"","publication_number":"US12053546B2","cleaned_patent_number":"12053546","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-06-29","publication_date":"2024-08-06","legal_status":"Granted"} | US12053546B2 Formulation | 06 Aug, 2024 | Granted | 29 Jun, 2032 | |
{"application_id":"45404","ingredient":"ISOTRETINOIN","trade_name":"ABSORICA LD","family_id":"b98a7da940e54970b957","publication_number":"US9750711B2","cleaned_patent_number":"9750711","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-05-29","publication_date":"2017-09-05","legal_status":"Granted"} | US9750711B2 Formulation | 05 Sep, 2017 | Granted | 29 May, 2035 | |
{"application_id":"45417","ingredient":"ISOTRETINOIN","trade_name":"ABSORICA LD","family_id":"f598b295a6a9471daf9e","publication_number":"US9700535B2","cleaned_patent_number":"9700535","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-08-04","publication_date":"2017-07-11","legal_status":"Granted"} | US9700535B2 Formulation | 11 Jul, 2017 | Granted | 04 Aug, 2035 | |
{"application_id":"55282","ingredient":"BENZOYL PEROXIDE; TRETINOIN","trade_name":"TWYNEO","family_id":"030daabb1d6e4c5e9a0a","publication_number":"US10420743B2","cleaned_patent_number":"10420743","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2038-07-12","publication_date":"2019-09-24","legal_status":"Granted"} | US10420743B2 | 24 Sep, 2019 | Granted | 12 Jul, 2038 | |
{"application_id":"63433","ingredient":"TRETINOIN","trade_name":"ALTRENO","family_id":"6a83c2ebc21e4b309ac3","publication_number":"US11324710B2","cleaned_patent_number":"11324710","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2038-08-22","publication_date":"2022-05-10","legal_status":"Granted"} | US11324710B2 | 10 May, 2022 | Granted | 22 Aug, 2038 | |
{"application_id":"63428","ingredient":"TRETINOIN","trade_name":"ALTRENO","family_id":"6a83c2ebc21e4b309ac3","publication_number":"US10653656B2","cleaned_patent_number":"10653656","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2038-08-22","publication_date":"2020-05-19","legal_status":"Granted"} | US10653656B2 Formulation | 19 May, 2020 | Granted | 22 Aug, 2038 | |
{"application_id":"114972","ingredient":"BENZOYL PEROXIDE; TRETINOIN","trade_name":"TWYNEO","family_id":"8724b062c3ff4800864f","publication_number":"US2023248687A1","cleaned_patent_number":"12295935","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2040-12-27","publication_date":"2025-05-13","legal_status":"Patented case"} | US12295935B2 | 13 May, 2025 | Patented case | 27 Dec, 2040 | |
{"application_id":"164409","ingredient":"BENZOYL PEROXIDE; TRETINOIN","trade_name":"TWYNEO","family_id":"","publication_number":"US12257348B2","cleaned_patent_number":"12257348","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2041-05-23","publication_date":"2025-03-25","legal_status":"Granted"} | US12257348B2 Formulation | 25 Mar, 2025 | Granted | 23 May, 2041 | |
{"application_id":"138445","ingredient":"BENZOYL PEROXIDE; TRETINOIN","trade_name":"TWYNEO","family_id":"","publication_number":"","cleaned_patent_number":"12133919","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2041-05-23","publication_date":"2024-11-05","legal_status":"Patented Case"} | US12133919B2 Formulation | 05 Nov, 2024 | Patented Case | 23 May, 2041 |
Latest clinical trials and research studies for this ingredient
NCT ID | Title | Status | Phase | Conditions | Start Date | Completion Date |
---|
Manufacturing Locations
Unlock access to all suppliers of Tretinoin
Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.